292 related articles for article (PubMed ID: 31392480)
1. Gastric cancer and image-derived quantitative parameters: Part 2-a critical review of DCE-MRI and
Tang L; Wang XJ; Baba H; Giganti F
Eur Radiol; 2020 Jan; 30(1):247-260. PubMed ID: 31392480
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the diagnostic accuracy of diffusion-weighted and dynamic contrast-enhanced MRI with
Diez AIG; Fuster D; Morata L; Torres F; Garcia R; Poggio D; Sotes S; Del Amo M; Isern-Kebschull J; Pomes J; Soriano A; Brugnara L; Tomas X
Eur J Radiol; 2020 Nov; 132():109299. PubMed ID: 33032207
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic Performance of Dynamic Contrast-Enhanced MRI and
Zhang Y; Zhao H; Liu Y; Zeng M; Zhang J; Hao D
Acad Radiol; 2022 Dec; 29(12):1842-1851. PubMed ID: 35396157
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric functional MRI and
Martens RM; Koopman T; Lavini C; Ali M; Peeters CFW; Noij DP; Zwezerijnen G; Marcus JT; Vergeer MR; Leemans CR; de Bree R; de Graaf P; Boellaard R; Castelijns JA
Eur Radiol; 2021 Feb; 31(2):616-628. PubMed ID: 32851444
[TBL] [Abstract][Full Text] [Related]
6. 18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
Hall DO; Hooper CE; Searle J; Darby M; White P; Harvey JE; Braybrooke JP; Maskell NA; Masani V; Lyburn ID
Nucl Med Commun; 2018 Feb; 39(2):161-170. PubMed ID: 29300270
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer and imaging biomarkers: Part 1 - a critical review of DW-MRI and CE-MDCT findings.
Giganti F; Tang L; Baba H
Eur Radiol; 2019 Apr; 29(4):1743-1753. PubMed ID: 30280246
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated
Kelly-Morland C; Rudman S; Nathan P; Mallett S; Montana G; Cook G; Goh V
BMC Cancer; 2017 Jun; 17(1):392. PubMed ID: 28578690
[TBL] [Abstract][Full Text] [Related]
9. Correlation between histogram-based DCE-MRI parameters and 18F-FDG PET values in oropharyngeal squamous cell carcinoma: Evaluation in primary tumors and metastatic nodes.
Vidiri A; Gangemi E; Ruberto E; Pasqualoni R; Sciuto R; Sanguineti G; Farneti A; Benevolo M; Rollo F; Sperati F; Spasiano F; Pellini R; Marzi S
PLoS One; 2020; 15(3):e0229611. PubMed ID: 32119697
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of dynamic gadoxetic-acid-enhanced MRI and PET/CT compared in patients with liver metastases from neuroendocrine neoplasms.
Armbruster M; Zech CJ; Sourbron S; Ceelen F; Auernhammer CJ; Rist C; Haug A; Singnurkar A; Reiser MF; Sommer WH
J Magn Reson Imaging; 2014 Aug; 40(2):457-66. PubMed ID: 24347148
[TBL] [Abstract][Full Text] [Related]
11. Dynamic contrast-enhanced MRI of gastric cancer: Correlations of the pharmacokinetic parameters with histological type, Lauren classification, and angiogenesis.
Ma L; Xu X; Zhang M; Zheng S; Zhang B; Zhang W; Wang P
Magn Reson Imaging; 2017 Apr; 37():27-32. PubMed ID: 27840273
[TBL] [Abstract][Full Text] [Related]
12. Tumor metabolism and perfusion ratio assessed by 18F-FDG PET/CT and DCE-MRI in breast cancer patients: Correlation with tumor subtype and histologic prognostic factors.
An YS; Kang DK; Jung YS; Han S; Kim TH
Eur J Radiol; 2015 Jul; 84(7):1365-70. PubMed ID: 25886700
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced MRI versus
Feng F; Qiang F; Shen A; Shi D; Fu A; Li H; Zhang M; Xia G; Cao P
Chin J Cancer Res; 2018 Feb; 30(1):21-30. PubMed ID: 29545716
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
Tateishi U; Miyake M; Nagaoka T; Terauchi T; Kubota K; Kinoshita T; Daisaki H; Macapinlac HA
Radiology; 2012 Apr; 263(1):53-63. PubMed ID: 22438441
[TBL] [Abstract][Full Text] [Related]
15. Quantitative parameters derived from
Meng Z; Zhang L; Huang C; Piao Y; Chen X; Xian J
Neuroradiology; 2022 Nov; 64(11):2153-2162. PubMed ID: 36121469
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of spinal lesions using perfusion parameters measured by DCE-MRI and metabolism parameters measured by PET/CT.
Zhang J; Chen Y; Zhang Y; Zhang E; Yu HJ; Yuan H; Zhang Y; Su MY; Lang N
Eur Spine J; 2020 May; 29(5):1061-1070. PubMed ID: 31754820
[TBL] [Abstract][Full Text] [Related]
18. Improving MR sequence of 18F-FDG PET/MR for diagnosing and staging gastric Cancer: a comparison study to
Zheng D; Liu Y; Liu J; Li K; Lin M; Schmidt H; Xu B; Tian J
Cancer Imaging; 2020 Jun; 20(1):39. PubMed ID: 32546207
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced MRI, diffusion-weighted MRI and
Ng SH; Liao CT; Lin CY; Chan SC; Lin YC; Yen TC; Chang JT; Ko SF; Fan KH; Wang HM; Yang LY; Wang JJ
Eur Radiol; 2016 Nov; 26(11):4162-4172. PubMed ID: 26911889
[TBL] [Abstract][Full Text] [Related]
20. Added value of [
Yoon I; Bae JS; Yoo J; Lee DH; Kim SH
Eur Radiol; 2021 Oct; 31(10):7834-7844. PubMed ID: 33768290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
